Evommune (NYSE:EVMN) Update / briefing Transcript

Evommune (NYSE:EVMN) Update / briefing February 10, 2026 08:30 AM ET Company ParticipantsAndreas Argyrides - Executive DirectorGavin Clark-Gartner - Managing DirectorGregory S. Moss - Chief Financial OfficerJeegar Patel - Chief Scientific OfficerJudah Frommer - Executive DirectorLuis Peña - Co-Founder, President and CEOMark Jackson - Senior Vice President of Clinical DevelopmentPaul Leyland - Communications ConsultantPrakhar Agrawal - Managing DirectorThomas J. Smith - Senior Managing DirectorConference Cal ...